Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

-3.09%

Category Returns

-3.88%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) 0.86 0.16 -3.09 -1.58 22.33 19.55 18.65 26.01 20.84
Equity - Sectoral Fund - Pharma & Health Care 0.69 -0.87 -3.88 -5.27 17.18 20.45 23.15 22.30 17.28

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    498.0877

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032

  • Phone

    (040) 23312454 23320751 23320752

  • Fax

    (040) 23311968

  • Email

    customercare@karvy.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 98.14
Others : 1.86

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 123675.69 13.87
Divi's Laboratories Limited 82383.08 9.24
Lupin Limited 75469 8.47
Dr. Reddy's Laboratories Limited 50849.23 5.7
Cipla Limited 47399 5.32
Apollo Hospitals Enterprise Limited 47338.35 5.31
Vijaya Diagnostic Centre Limited 31972.86 3.59
MedPlus Health Services Limited 29617.14 3.32
Ajanta Pharma Limited 28129.27 3.16
Gland Pharma Limited 26690.25 2.99
Abbott India Limited 25693.25 2.88
JB Chemicals & Pharmaceuticals Limited 23583.25 2.65
Aurobindo Pharma Limited 22721.6 2.55
Mankind Pharma Limited 21575.23 2.42
Zydus Lifesciences Limited 19440.14 2.18
Narayana Hrudayalaya Limited 19107.58 2.14
GlaxoSmithKline Pharmaceuticals Limited 18753.11 2.1
Triparty Repo 17798.49 2
Torrent Pharmaceuticals Limited 16913.28 1.9
Pfizer Limited 16808.32 1.89
Fortis Healthcare Limited 16556.55 1.86
Thyrocare Technologies Limited 16100.91 1.81
Alkem Laboratories Limited 15629.11 1.75
Sanofi India Limited 14098.75 1.58
Orchid Pharma Limited 11258.5 1.26
Suraksha Diagnostic Limited 10752.27 1.21
Sanofi Consumer Healthcare India Limited 10527.83 1.18
Syngene International Limited 9655.8 1.08
Dr. Lal Path Labs Limited 8674.52 0.97
Indoco Remedies Limited 6095.62 0.68
Sai Life Sciences Limited 4728.14 0.53
AstraZeneca Pharma India Limited 4680.99 0.53
Healthcare Global Enterprises Limited 4404.46 0.49
Emcure Pharmaceuticals Limited 4341.3 0.49
IPCA Laboratories Limited 4039.85 0.45
Krishna Institute Of Medical Sciences Limited 2761.47 0.31
Concord Biotech Limited 2470.25 0.28
Cash Margin - CCIL 105.89 0.01
Net Current Assets -1311.29 -0.15

Sectors - Holding Percentage

Sector hold percentage
Healthcare 97.06%
Miscellaneous 2%
Business Services 1.08%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 -1.34 3.53 17.66 38.36 0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 -1.16 1.37 12.75 35.99 24.39
LIC MF Healthcare Fund-Regular Plan-Growth 51.46 -2.08 0.23 12.9 32.58 17.56
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 -2.22 0.65 12.3 32.01 20.5
DSP Healthcare Fund - Regular Plan - Growth 1243.08 -1.52 -0.8 13.3 31.2 21.89
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 7.7 -2.51 1 13.35 29.6 22.95
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 138.39 -2.71 0.85 11.35 29.32 18.71
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 512.42 -2.04 0.32 9.21 28.51 20.99
Kotak Healthcare Fund - Regular Plan - Growth Option 214.38 -2.24 2.06 11.75 28.34 0
Mirae Asset Healthcare Fund -Regular Growth 1583.14 -1.8 -0.77 8.99 28.29 18.21

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 61973.76 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 61646.36 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 61027.03 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 60999.55 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 60372.55 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 56468.75 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 51566.11 -6.79 -7 -5.92 17.7 22.29
Nippon India Small Cap Fund - Growth Plan - Growth Option 50422.78 -6.79 -7 -5.92 17.7 22.29
CPSE ETF 46793.08 -1.77 -8.33 -14.39 22.56 38.25